Planned Parenthood v. Taft ( 2006 )


Menu:
  •                               RECOMMENDED FOR FULL-TEXT PUBLICATION
    Pursuant to Sixth Circuit Rule 206
    File Name: 06a0068p.06
    UNITED STATES COURT OF APPEALS
    FOR THE SIXTH CIRCUIT
    _________________
    X
    Plaintiffs-Appellees, -
    PLANNED PARENTHOOD CINCINNATI REGION, et al.
    -
    -
    -
    No. 04-4371
    v.
    ,
    >
    BOB TAFT, et al.,                                       -
    Defendants-Appellants. -
    N
    Appeal from the United States District Court
    for the Southern District of Ohio at Cincinnati.
    No. 04-00493—Susan J. Dlott, District Judge.
    Argued: December 7, 2005
    Decided and Filed: February 24, 2006
    Before: MOORE, ROGERS, and McKEAGUE, Circuit Judges.
    _________________
    COUNSEL
    ARGUED: Anne Berry Strait, OFFICE OF THE ATTORNEY GENERAL, CHARITABLE LAW
    SECTION, Columbus, Ohio, for Appellants. Nicole G. Berner, PLANNED PARENTHOOD
    FEDERATION OF AMERICA, Washington, D.C., for Appellees. ON BRIEF: Anne Berry Strait,
    OFFICE OF THE ATTORNEY GENERAL, CHARITABLE LAW SECTION, Columbus, Ohio, Sharon
    A. Jennings, Holly J. Hunt, OFFICE OF THE ATTORNEY GENERAL OF OHIO, CONSTITUTIONAL
    OFFICES SECTION, Columbus, Ohio, for Appellants. Nicole G. Berner, PLANNED PARENTHOOD
    FEDERATION OF AMERICA, Washington, D.C., Alphonse A. Gerhardstein, GERHARDSTEIN,
    BRANCH & LAUFMAN, Cincinnati, Ohio, Roger K. Evans, Mimi Y.C. Liu, PLANNED PARENTHOOD
    FEDERATION OF AMERICA, New York, New York, Jeffrey M. Gamso, AMERICAN CIVIL
    LIBERTIES UNION OF OHIO FOUNDATION, Cleveland, Ohio, Jessie Hill, CASE WESTERN
    RESERVE UNIVERSITY SCHOOL OF LAW, Cleveland, Ohio, for Appellees. Peter O. Safir, Kelly A.
    Falconer, COVINGTON & BURLING, Washington, D.C., for Amicus Curiae.
    McKEAGUE, J., delivered the opinion of the court, in which ROGERS, J., joined. MOORE, J. (p.
    13), delivered a separate opinion concurring in part.
    _________________
    OPINION
    _________________
    McKEAGUE, Circuit Judge. Plaintiffs challenge an Ohio statute which prohibits the off-label use
    of the abortion drug mifepristone (more commonly known as RU-486). The district court granted a
    preliminary injunction enjoining enforcement of the statute on two alternative grounds. The State timely
    1
    No. 04-4371                 Planned Parenthood, et al. v. Taft, et al.                                                 Page 2
    filed an interlocutory appeal. For the following reasons, we hold that the district court’s primary holding
    was error, but affirm the reasoning of the district court’s alternative holding. Nevertheless, we vacate the
    district court’s order in part and remand for consideration of the appropriate scope of injunctive relief in
    light of the United States Supreme Court’s recent decision in Ayotte v. Planned Parenthood of Northern
    New England, — U.S. —, 
    126 S. Ct. 961
    (2006).
    I.
    Until 2000 most first trimester abortions in this country were surgical abortions performed by
    vacuum aspiration or curettage. In September of 2000, the Food and Drug Administration (“FDA”)
    approved mifepristone, a pill used to induce an abortion without surgical intervention, for manufacture and
    use in the United States. This approval was based on clinical trials which involved the oral ingestion of 600
    mg of mifepristone followed two days later by the oral ingestion of 0.4 mg of misoprostol.1 Upon
    examining the results of these trials, the FDA concluded that this regimen was a safe and effective method
    of medical abortion when employed up through forty-nine days’ gestation. Consequently, the FDA
    approved the use of mifepristone. The FDA labeling and approval letter indicated that the appropriate
    treatment regimen was to administer 600 mg of mifepristone orally followed by 0.4 mg of misoprostol
    administered orally two days later and that mifepristone was not to be administered after forty-nine days’
    gestation.
    Absent state regulation, once a drug has been approved by the FDA, doctors may prescribe it for
    indications and in dosages other than those expressly approved by the FDA. This is a widely employed
    practice known as “off-label” use. Off-label use does not violate federal law or FDA regulations because
    the FDA regulates the marketing and distribution of drugs in the United States, not the practice of medicine,
    which is the exclusive realm of individual states. Subsequent to the clinical trials relied upon by the FDA,
    other trials were conducted experimenting with different possible regimens for administering mifepristone
    and misoprostol. As a result of this research, an off-label protocol was developed consisting of 200 mg of
    mifepristone administered orally followed one to three days later by 0.8 mg of misoprostol administered
    vaginally. This regimen is employed up to sixty-three days’ gestation and is known as the Schaff protocol
    after the doctor whose research primarily led to its development. The Schaff protocol is the method of
    medical (i.e., non-surgical) abortion recommended by the National Abortion Federation and Planned
    Parenthood Federation of America and has come to be widely employed across the United States.2
    In 2004, the Ohio General Assembly enacted H.B. 126 (“the Act”) to regulate the use of mifepristone
    in Ohio. Specifically, the Act provides:
    No person shall knowingly give, sell, dispense, administer, otherwise provide, or prescribe
    RU-486 (mifepristone) to another for the purpose of inducing an abortion . . . unless the
    person . . . is a physician, the physician satisfies all the criteria established by federal law
    that a physician must satisfy in order to provide RU-486 (mifepristone) for inducing
    abortions, and the physician provides the RU-486 (mifepristone) to the other person for the
    purpose of inducing an abortion in accordance with all provisions of federal law that govern
    the use of RU-486 (mifepristone) for inducing abortions.
    1
    The mifepristone is an abortifacient which terminates the pregnancy by detaching the gestational sac from the uterine wall.
    The misoprostol is a prostaglandin which induces the contractions necessary to expel the fetus and other products of conception
    from the uterus.
    2
    After this appeal was briefed, the American College of Obstetricians and Gynecologists (ACOG) issued a practice bulletin
    stating that compared with the FDA protocol the Schaff protocol is “associated with a decreased rate of continuing pregnancies,
    decreased time to expulsion, fewer side effects, improved complete abortion rates, and lower cost for women with pregnancies
    up to 63 days’ gestation.” The previous relevant ACOG practice bulletin from 2001 had only recommended using the FDA
    protocol and specifically stated that medical abortion should not be performed after forty-nine days’ gestation.
    No. 04-4371                  Planned Parenthood, et al. v. Taft, et al.                                                     Page 3
    Ohio Rev. Code Ann. § 2919.123(A). The Act defines “federal law” as, “any law, rule, or regulation of the
    United States or any drug approval letter of the food and drug administration of the United States that
    governs or regulates the use of RU-486 (mifepristone) for the purpose of inducing abortions.” Ohio Rev.
    Code Ann. § 2919.123(F). This arguably requires doctors who prescribe mifepristone for the purpose of
    inducing an abortion to do so only in accordance with the indication, regimen and distribution restrictions
    approved by the FDA. In other words, the Act prohibits the “off-label” use of mifepristone.
    According to the State, the Act was passed because abortion providers in Ohio were openly using
    the Schaff protocol and “because legislators became aware      that several women had died or been severely
    injured recently as a result of their use of mifepristone.”3 Ohio legislators concluded that the FDA had only
    approved one specific protocol for the administration of mifepristone because that was the only safe and
    effective protocol. Therefore, they banned all other uses of mifepristone to protect Ohio women from unsafe
    and ineffective mifepristone protocols.
    The Act was scheduled to go into effect on September 23, 2004. Dr. Roslyn Kade, Dr. Laszlo Sogor,
    and various Planned Parenthood chapters in Ohio (collectively, “Plaintiffs”) brought this action challenging
    the constitutionality of the Act on the grounds that it (1) is unconstitutionally vague, (2) violates a patient’s
    right to bodily integrity by compelling surgery in circumstances where a medical abortion would otherwise
    be the desired or appropriate treatment, (3) lacks the constitutionally-mandated exception to allow otherwise
    restricted practices where they are necessary to preserve a woman’s health or life, and (4) imposes an undue
    burden on a patient’s right to choose abortion by prohibiting a safe and common method of pre-viability
    abortion. Plaintiffs named as defendants Bob Taft, the Governor of Ohio, and Jim Petro, the Attorney
    General of Ohio, in their official capacities, and Michael K. Allen, as Prosecuting Attorney for Hamilton
    County, Ohio, and as a representative of a class of all prosecuting attorneys in Ohio (collectively, “the
    State”).
    Before the Act went into effect, Plaintiffs moved for a preliminary injunction. A two-day
    evidentiary hearing was held in which each side was allotted a total of three hours to present testimony and
    cross-examine opposing witnesses. Plaintiffs presented the expert testimony of Dr. Eric Schaff and Dr.
    Laszlo Sogor. The State presented the testimony of Dr. Susan Crockett. The district court granted the
    motion for a preliminary injunction on the basis that Plaintiffs had established a strong likelihood of
    prevailing on their third argument, that the statute needs a health or life exception. The district court did
    not address the other three arguments. The State timely filed an interlocutory appeal.
    II.
    The Sixth Circuit’s review of a district court’s grant of a preliminary injunction is limited to an abuse
    of discretion standard. Lexmark Int’l, Inc. v. Static Control Components, Inc., 
    387 F.3d 522
    , 532 (6th Cir.
    2004); ACLU v. Taft, 
    385 F.3d 641
    , 645 (6th Cir. 2004); United States v. Edward Rose & Sons, 
    384 F.3d 258
    , 261 (6th Cir. 2004) ; Sec’y of Labor v. 3Re.com, Inc., 
    317 F.3d 534
    , 537 (6th Cir. 2003). The district
    court’s determination will be disturbed only if it relied upon clearly erroneous findings of fact, improperly
    applied the governing law, or used an erroneous legal standard. Nightclubs, Inc. v. City of Paducah, 
    202 F.3d 884
    , 888 (6th Cir. 2000). Under this standard, the court must review the district court’s legal
    conclusions de novo and its factual findings for clear error. Taubman Co. v. Webfeats, 
    319 F.3d 770
    , 774
    (6th Cir. 2003).
    3
    The record in this case does not contain any indication that any woman died or was severely injured as a result of an off-label
    mifepristone protocol. The only source cited did indicate that one death had been reported, but that was due to the fact that
    mifepristone was administered to a woman with an ectopic pregnancy. All parties unequivocally agree that mifepristone is
    contraindicated for ectopic pregnancies at any gestational age. Two cases of severe bacterial infection and one heart attack were
    also reported in women who had taken mifepristone, but no causal link was established.
    No. 04-4371                Planned Parenthood, et al. v. Taft, et al.                                               Page 4
    III.
    The district court held that “a long line of Supreme Court authority mandates and reaffirms that the
    Due Process Clause of the Constitution requires that every statute regulating abortion include an exception
    for those situations where necessary, in appropriate medical judgment, to preserve the life and health of the
    mother.” These cases are said to impose a “per se” requirement on all abortion statutes.4 The State argues
    that the requirement of a health or life exception does not apply to every single statute which regulates
    abortion, but only to those statutes which regulate abortion in a manner which might actually endanger
    women’s health or lives. The district court offered little analysis to support its adoption of a per se
    requirement, and close scrutiny of the case law reveals that no such blanket requirement has been imposed.
    In Planned Parenthood v. Casey the Supreme Court reaffirmed three basic principles which were
    originally set forth in Roe v. Wade: (1) previability a woman has a right to obtain an abortion without the
    state imposing an undue burden on her decision, (2) postviability the state may restrict abortion except when
    a woman’s health or life is in danger, and (3) throughout a pregnancy the state has legitimate interests in
    protecting both “the health of the woman and the life of the fetus that may become a child.” Planned
    Parenthood v. Casey, 
    505 U.S. 833
    , 846 (1992). The Court later clarified that a state may not restrict
    abortion procedures which are necessary to preserve the health or life of the mother at any time during a
    pregnancy. Stenberg v. Carhart, 
    530 U.S. 914
    , 930 (2000) (“Since the law requires a health exception in
    order to validate even a postviability abortion regulation, it at a minimum requires the same in respect to
    previability regulation.”).
    The State’s challenge to the district court’s use of a per se requirement is a conflation of two similar,
    but separate, arguments. The first argument is that a previability regulation must only have a health or life
    exception if the lack of such an exception imposes an undue burden. The second is that there is no blanket
    requirement anywhere in the case law that every single regulation which affects abortion must have a health
    or life exception. The State’s briefing varies between treating these two propositions as separate arguments,
    treating them as the same argument simply restated in different terms, and treating the second proposition
    as the logical result of the first proposition. This creates confusion because although the arguments are
    closely related, it is not correct to say that a previability regulation must only have a health or life exception
    if the lack of such an exception imposes an undue burden, for reasons explained below, while it is correct
    to say that there is no per se requirement for a health or life exception in all abortion statutes. The best way
    to avoid this confusion is to address each proposition separately.
    According to the State, Casey mandates that all statutes affecting previability abortions are evaluated
    using the undue burden standard, including to determine whether such a statute must contain a health or life
    exception. Therefore, the State argues such an exception is only necessary if the absence of an exception
    would impose an undue burden. While the State’s construction of Casey might be plausible in the absence
    of any subsequent relevant case law, the Supreme Court has since made it abundantly clear that the necessity
    and adequacy of a health or life exception is a question entirely separate from the undue burden analysis.
    See 
    Carhart, 530 U.S. at 930
    . In Carhart the Court struck down the statute at issue as it related to
    previability abortions on the basis that it imposed an undue burden. 
    Id. However, it
    unequivocally stated
    that the statute needed a health exception and the lack of that exception was a separate and independent
    basis for striking down the statute. Id.; see also Ayotte v. Planned Parenthood of Northern New England,
    — U.S. —, 
    126 S. Ct. 961
    , 969 (2006). This analysis dooms the State’s argument that a health or life
    exception is only necessary if its absence would impose an undue burden.
    The next component of the State’s argument is a direct challenge to the district court’s imposition
    of a per se requirement. The Supreme Court cases the district court cited contain only one statement which
    4
    Other circuits have made reference to a “per se” requirement but with inconsistent meanings. See Richmond Med. Center
    for Women v. Hicks, 
    409 F.3d 619
    , 625 (4th Cir. 2005); Reproductive Health Services of Planned Parenthood v. Nixon, 
    429 F.3d 803
    , 805-06 (8th Cir. 2005); Planned Parenthood v. Wasden, 
    376 F.3d 908
    , 922 (9th Cir. 2004).
    No. 04-4371             Planned Parenthood, et al. v. Taft, et al.                                      Page 5
    offers textual support for a per se requirement. In Casey the Court stated that the second essential holding
    of Roe v. Wade was “a confirmation of the State’s power to restrict abortions after fetal viability, if the law
    contains exceptions for pregnancies which endanger the woman’s life or health.” 
    Casey, 505 U.S. at 846
    .
    However, this lone statement must be read in the context of the many other statements in Casey, Carhart,
    and Ayotte which frame the same general principle in slightly, but significantly, different terms. For
    example, the Casey Court stated that “the essential holding of Roe forbids a State to interfere with a
    woman’s choice to undergo an abortion procedure if continuing her pregnancy would constitute a threat to
    her health.” 
    Id. at 880;
    see also 
    Carhart, 530 U.S. at 931
    (“[T]he governing standard requires an exception
    where it is necessary, in appropriate medical judgment for the preservation of the life or health of the
    mother.”); 
    Ayotte, 126 S. Ct. at 967
    (“[O]ur precedents hold, that a State may not restrict access to abortions
    that are necessary, in appropriate medical judgment, for preservation of the life or health of the mother.”).
    The latter, more predominant, way the health or life exception requirement is expressed indicates that a
    statute which regulated abortion, but did not pose any significant risk to a woman’s health or life, would not
    violate the health or life exception requirement.
    Furthermore, the Supreme Court’s application of the health or life exception requirement further
    undermines the slender textual support for a per se requirement. In Carhart, the Court invalidated
    Nebraska’s ban on partial-birth abortion because although it contained a life exception, it did not contain
    a health exception. 
    Carhart, 530 U.S. at 930
    -38. The language throughout the opinion shows that before
    coming to this conclusion the Court carefully considered whether a health exception was necessary. 
    Id. at 934-37
    (“We find these eight arguments insufficient to demonstrate that Nebraska’s law needs no health
    exception.” “Given these medically related evidentiary circumstances, we believe the law requires a health
    exception.”). If an abortion statute is per se unconstitutional without a health or life exception, the Court
    would only have had to note that the statute at issue regulated abortion and that it did not have a health
    exception. Those two facts alone (neither of which was disputed) would have been sufficient to find a
    constitutional violation. Both the Court’s predominant discussion of the health or life exception requirement
    and its application demonstrate that there is no such per se requirement.
    Neither can support for a per se requirement be found in any of the cases from other circuits cited
    in the briefs. Although the First Circuit has stated that a health or life exception is a per se requirement, in
    the same case it went on to observe that all three times an abortion statute has been challenged in the
    Supreme Court, “the Court has indicated that an exception must be provided when the restriction would
    place a woman’s health at risk.” Planned Parenthood of Northern New England v. Heed, 
    390 F.3d 53
    , 59-
    60 (1st Cir. 2004) (emphasis added), vacated and remanded on other grounds sub nom. Ayotte v. Planned
    Parenthood of Northern New England, — U.S. —, 
    126 S. Ct. 961
    (2006). Since the court expressed the
    requirement both ways and did not examine the issue in detail, its commentary is not helpful one way or the
    other.
    At first glance, it appears that the Ninth Circuit has followed a per se approach because it has stated
    that “[a]n adequate health exception . . . is a per se constitutional requirement.” Planned Parenthood v.
    Wasden, 
    376 F.3d 908
    , 922 (9th Cir. 2004). However, the context shows that the Ninth Circuit was not
    imposing a per se requirement as the district court did here, but rather holding that determining whether a
    health or life exception is constitutionally necessary “requires an analysis separate from any undue burden
    inquiry.” 
    Id. The Ninth
    Circuit’s use of the phrase “per se requirement” describes the fact that the health
    or life exception requirement is separate and distinct from the undue burden standard. See 
    id. The Wasden
    court does not use the phrase “per se requirement” the same way that the parties and the district court in this
    litigation have used it, which is to refer to the proposition that every law which affects abortion must contain
    a health or life exception. Consequently, Wasden does not support a per se requirement that all abortion
    statutes must have a health or life exception.
    The Fourth and Eighth Circuits have also stated that the health or life exception requirement is a “per
    se constitutional rule.” Richmond Med. Center for Women v. Hicks, 
    409 F.3d 619
    , 625 (4th Cir. 2005);
    Reproductive Health Services of Planned Parenthood v. Nixon, 
    429 F.3d 803
    , 805-06 (8th Cir. 2005);
    No. 04-4371             Planned Parenthood, et al. v. Taft, et al.                                       Page 6
    Carhart v. Gonzales, 
    413 F.3d 791
    , 796 (8th Cir. 2005). However, once again the context indicates that
    neither circuit was embracing the test employed by the district court in this case. 
    Nixon, 429 F.3d at 805-06
    ;
    see also 
    Hicks, 409 F.3d at 625-26
    ; 
    Gonzales, 413 F.3d at 796-97
    . Neither were these courts using the
    phrase “per se rule” in the same sense as the Ninth Circuit. The cases decided by the Fourth and Eighth
    Circuits involved statutes banning partial birth abortion which were similar to the statute struck down by
    the Carhart Court for lack of a health exception. The Fourth Circuit case was decided first and used the
    phrase “per se constitutional rule” to describe the fact that the Supreme Court had already determined that
    statutes banning partial birth abortions were required to contain a health exception as well as a life
    exception. 
    Hicks, 409 F.3d at 625-26
    . The Fourth Circuit concluded that the body of medical evidence
    relevant to whether substantial medical authority indicated that a ban of partial birth abortion created a
    significant health risk did not need to be “reproduced in every subsequent challenge to a partial birth
    abortion statute lacking a health exception.” 
    Id. The Eighth
    Circuit reached the same conclusion and
    referred to the “per se rule” that a partial birth abortion ban must contain a health exception (at least until
    a state is able to demonstrate that medical procedures have advanced to the point where the Carhart Court’s
    conclusion is no longer valid). 
    Nixon, 429 F.3d at 805-06
    ; 
    Gonzales, 413 F.3d at 796-97
    .
    The Tenth Circuit has also faced the issue of whether a particular abortion statute needed to contain
    a health or life exception. Planned Parenthood v. Owens, 
    287 F.3d 910
    (10th Cir. 2002). The statute at
    issue required a forty-eight hour waiting period after parental notification. 
    Id. at 920.
    The Tenth Circuit
    concluded that an exception was necessary based on the observation that experts from both sides agreed that
    there were medical emergencies which could arise which would endanger the health or life of a minor if she
    could not obtain an abortion before the expiration of the waiting period. 
    Id. The court’s
    discussion of
    whether the statute at issue could affect the health or life of a minor is an implicit rejection of a per se
    requirement that all abortion statutes contain a health or life exception regardless of whether the statute
    endangers the health of life of the woman. See 
    id. at 919-20.
             In light of the way the Supreme Court has both expressed and applied the health or life exception
    requirement, the district court’s holding that the requirement is a per se rule was erroneous. Consequently,
    it is necessary to consider the district court’s alternative holding.
    IV.
    The district court held that Plaintiffs had established a significant likelihood of prevailing on the
    merits even if there is no per se requirement. The district court held that at a minimum the Supreme Court
    case law requires the State to demonstrate that there are no circumstances under which a statute would result
    in significant health risks in order to preserve a statute from being held unconstitutional due to lack of a
    health or life exception. The State challenges both the district court’s placement of the burden of proof on
    the State and the district court’s conclusion that the evidence submitted at the preliminary injunction hearing
    was sufficient to show a substantial likelihood that the Act must contain a health or life exception. We find
    that there is no need to address the burden of proof issue because the evidence submitted was sufficient to
    merit the district court’s conclusion as to the necessity of a health or life exception regardless of which party
    had the burden of proof.
    The legal standard for determining when a statute which affects abortion must contain a health or
    life exception was succinctly set forth by the Carhart Court.
    By no means must a State grant physicians unfettered discretion in their selection of abortion
    methods. But where substantial medical authority supports the proposition that banning a
    particular abortion procedure could endanger women’s health Casey requires the statute to
    include a health exception when the procedure is necessary, in appropriate medical
    judgment, for the preservation of the life or health of the mother.
    No. 04-4371                 Planned Parenthood, et al. v. Taft, et al.                                                   Page 7
    
    Carhart, 530 U.S. at 938
    (internal quotations and citations omitted). An exception is constitutionally
    necessary where substantial medical authority indicates that a banned procedure would be safer than the
    other available procedures, not just when banning the procedure subjects a woman to risks from the
    pregnancy itself. 
    Id. at 931.
    As emphasized previously by this circuit, an exception is only necessary (and
    must only cover) circumstances where a statute poses a significant health risk. Id.; Women’s Medical Pro.
    Corp. v. Taft, 
    353 F.3d 436
    , 448-49 (6th Cir. 2003). Finally, an adequate showing of a significant health
    risk in certain circumstances is sufficient to require an exception even if those circumstances rarely occur.
    
    Carhart, 530 U.S. at 934
    (“The State cannot prohibit a person from obtaining treatment simply by pointing
    out that most people do not need it.”); see also 
    Ayotte, 126 S. Ct. at 967
    .
    At the preliminary injunction evidentiary hearing Plaintiffs introduced expert testimony from two
    doctors which established that, if enforced, the statute would result in significant risk to women’s health in
    particular, albeit narrow, circumstances. They pointed to the fact that the statute prohibits the use of
    mifepristone for a medical abortion after seven weeks’ gestation although many doctors would offer a
    mifepristone medical abortion as an option up to nine weeks’ gestation pursuant to the Schaff protocol in
    the following specific circumstances where other alternatives pose a significant risk to a woman’s health:
    a bicornuate (i.e. divided) uterus, extreme flexion of the uterus, large uterine fibroids, cervical stenosis,
    female genital mutilation, and other abnormalities of the female genital tract. While Plaintiffs’ experts did
    not challenge the fact that for most women surgical abortion is an alternative which does not present any
    more risk than medical abortion, they testified that for some women these health conditions make surgical
    abortion significantly more risky. For such women, a medical abortion using mifepristone would pose
    significantly less risk than undergoing a surgical abortion.
    The State’s expert, Dr. Crockett, stated in her affidavit that when surgical abortion is contraindicated
    because of a woman’s medical condition, a mifepristone medical abortion is also contraindicated because
    surgical abortion is necessary in the small percentage of cases in which the mifepristone medical abortion
    fails. However, Dr. Crockett did not, either in her affidavit or hearing testimony, contradict Plaintiffs’
    experts’ testimony that certain medical conditions render a surgical abortion more risky than a successful
    mifepristone medical abortion. An unsuccessful medical abortion would place a woman in the same
    position she would be in if a medical abortion was not available. Moreover, the record5 indicates that a
    mifepristone medical abortion would be successful at least ninety percent of the time. In light of the
    uncontested facts, Dr. Crockett’s sworn statement is unavailing. She is essentially asserting that no patient
    should be permitted to choose a less risky medical abortion over what both parties agree may be a
    significantly more risky surgical abortion for that patient simply because of a ten percent or less chance that
    the surgical abortion might be necessary anyway if the medical abortion fails. This is the only evidence the
    State proffered at the preliminary injunction stage which addresses Plaintiffs’ experts’ testimony        that in
    some circumstances a surgical abortion poses significantly greater risk than a medical abortion.6
    The State also points to the cross-examination of Plaintiff’s expert, Dr. Schaff, who agreed that a
    medical abortion can be safely performed using the drug methotrexate (which is not regulated by the Act)
    instead of mifepristone. However, on re-direct Dr. Schaff explained that while methotrexate is an excellent
    drug, using it for a medical abortion is far less safe than mifepristone. He explained the reason for this as
    follows:
    Methotrexate again is a cancer agent [in addition to being used for medical abortions]
    because it stops cells dividing. It’s not selective. It stops all cells that are rapidly dividing.
    An embryo or early pregnancy is rapidly dividing, and that’s why it works to end an early
    5
    The precise efficacy rate of the Schaff protocol at various gestational ages has been vigorously disputed. However, the
    highest failure rate claimed by the State is ten percent.
    6
    Since the State did not present any other evidence on this point, the list of circumstances enumerated by Plaintiffs’ experts
    under which surgical abortion can be significantly more risky is uncontested.
    No. 04-4371                 Planned Parenthood, et al. v. Taft, et al.                                                   Page 8
    pregnancy. But it also is toxic to all cells in the body; that’s why it also works as a cancer
    chemotherapeutic agent.
    The State offered no testimony or other evidence at the preliminary injunction hearing refuting Dr. Schaff’s
    opinion that using methotrexate for a medical abortion poses greater health risks than using mifepristone.
    Both of Plaintiffs’ experts testified that there are no other drugs besides methotrexate and
    mifepristone which can be used to perform a medical abortion. While Dr. Crockett asserted that there are
    a variety of other ways to evacuate a uterus medically besides using mifepristone, this assertion is irrelevant
    because mifepristone is not used to evacuate the uterus; it is used to terminate the pregnancy. Misoprostol
    (which is not regulated by the Act) is then administered to evacuate the uterus. The State did not provide
    any evidence that any drug other than methotrexate would be available for performing medical abortions
    between seven and nine weeks’ gestation if the Act took effect. Consequently, the medical authority
    available at the preliminary injunction phase of this case permitted the finding that using mifepristone is the
    safest available method of medical abortion and that in some circumstances a medical abortion using
    mifepristone would pose significantly less risk to the health or life of a discrete class of women than a
    surgical abortion.
    In its appellate brief, the State points to a case in which the Supreme Court upheld a statute which
    allowed only doctors (and not physician assistants) to perform abortions in spite of evidence that this
    regulation might not have been necessary to accomplish its stated purpose of increasing the safety of
    abortion procedures. See Mazurek v. Armstrong, 
    520 U.S. 968
    , 973 (1997). The State argues that there is
    even more reason to uphold the statute at issue here because there is evidence that the statute is necessary
    to make abortion procedures safer. Regardless of the accuracy of the State’s characterization of the
    evidence, the argument misses the mark. The issue of whether a statute is justified as a safety measure in
    general is not dispositive. As long as there are certain circumstances in which a statutorily-banned
    procedure is significantly safer, the statute must contain a health or life exception. The Mazurek case sheds
    no light on this issue because there was no indication or argument that the statute considered there would
    create a significant risk to any woman’s health or life. See Mazurek, 
    520 U.S. 968
    .
    The State goes on to make various arguments which can each be disposed of briefly. First, the State
    emphasizes that surgical abortion is a safe and available alternative. While true in the vast majority of
    situations, this is not dispositive because it does not address the expert testimony that there are some
    circumstances in which the surgical option is considerably more risky for some women. Next, the State
    points to the absence of any studies which show that a mifepristone medical abortion is the safest procedure
    under particular circumstances. However, the Supreme Court has made it clear that such studies are not
    necessary where there is expert testimony that a restricted procedure is safer than the alternatives. 
    Carhart, 530 U.S. at 936-37
    . The State goes on to claim that Plaintiffs’ own expert’s testimony shows that using
    mifepristone to induce medical abortions past seven weeks’ gestation is dangerous. This argument is
    unsupported in the record. According to the State, Dr. Schaff’s testimony indicates that his protocol is not
    as safe or effective as the FDA-approved protocol. Putting aside the accuracy of this statement (which is
    contested), the relative efficacy and safety of the two mifepristone protocols has nothing to do with whether
    a health or life exception is required. To answer this question the court must examine the difference
    between the safety of the banned procedure (mifepristone medical abortion) and the safety of other available
    procedures (surgical abortion or methotrexate medical abortion) after seven weeks’ gestation. The State
    does not point to any evidence which demonstrates that there is an alternative abortion procedure which is
    available after seven week’s gestation which is as safe  or safer than a mifepristone medical abortion for all
    medically foreseeable circumstances or conditions.7
    7
    The lack of such evidence at the preliminary injunction stage does not necessarily indicate that there is no such authority
    in the vast store of medical knowledge. Procedural factors inherent in the preliminary injunction determination–such as the
    compressed time frame in which to present testimony related to four complex constitutional issues, a relatively short period of
    time to prepare for the hearing, and the lack of available discovery–may well have had a role in the dearth of evidence introduced
    No. 04-4371                 Planned Parenthood, et al. v. Taft, et al.                                                     Page 9
    The evidence presented at the preliminary injunction stage does not adequately support the State’s
    claim that the Act may constitutionally omit a health or life exception. In Carhart the Supreme Court ruled
    that a health or life exception was necessary where the record demonstrated:(1) that the banned abortion
    procedure significantly obviated health risks in particular circumstances, (2) there was “a highly plausible
    record-based explanation of why that might be so,” (3) there was conflicting expert testimony over whether
    the banned procedure was safer, and (4) there was an absence of any clinical studies relevant to the issue.
    
    Carhart, 530 U.S. at 936-37
    . For purposes of determining whether to grant a preliminary injunction in this
    case, all of these requirements have been met. There was uncontroverted expert evidence that the restricted
    abortion procedure obviated health risks in particular circumstances. The testimony of Plaintiffs’ experts
    provided an explanation of why this might be the case. As this explanation was both uncontradicted and
    facially reasonable, it can be fairly characterized as “highly plausible.” At the preliminary injunction
    hearing the State did not effectively contest Plaintiffs’ evidence that the banned procedure could be safer
    than other available procedures. Finally, as in Carhart, here there were no clinical studies relevant to this
    particular issue. Accordingly, the evidence presented to the district court established at least as persuasive
    a case as that presented in Carhart that the abortion regulation at issue could pose a significant health risk
    to women with particular medical conditions. Consequently, the district court’s ruling that Plaintiffs
    established a strong likelihood of prevailing on the merits has not been shown to be erroneous.
    V.
    During the evidentiary hearing on the preliminary injunction, the district court recognized the State’s
    witness, Dr. Crockett, as an expert in the areas of obstetrics, gynecology and the FDA approval process but
    refused to allow Dr. Crockett8to testify as an expert regarding medical and surgical abortion or the critical
    review of medical literature. The State argues that refusing to recognize Dr. Crockett as an expert on
    medical and surgical abortion because she did not perform elective abortion procedures was an abuse of
    discretion. The State argues that performing elective abortion procedures is not a prerequisite to being an
    expert on such procedures and points out that such a rule would make it extremely difficult for governmental
    entities to secure the services of expert witnesses in such cases. The practical point is well taken, and the
    legal principle is sound. As with any other procedure or topic, an individual can acquire expertise regarding
    elective abortion procedures through a variety of means other than actually performing the precise procedure
    at issue. See, e.g., Berry v. City of Detroit, 
    25 F.3d 1342
    , 1350 (6th Cir. 1994) (observing that an
    aeronautical engineer would be qualified to testify about the flight of a bumblebee based on general flight
    principles even if he had never actually seen a bumblebee).
    Furthermore, the record is far from clear as to whether the district court judge even based her ruling
    solely on the fact that Dr. Crockett did not perform elective abortions. The district judge explicitly stated
    that whether a doctor performs elective abortions “has nothing to do with my recognizing someone as an
    expert or not. The only thing, I’m not looking at their point of view; I’m just looking at the experience and
    qualifications they need to be designated by the Court as an expert.” (JA 594.) Nevertheless, viewing the
    record as a whole, there is some merit to the State’s argument that in spite of what the district court said,
    the only conceivable reason for failing to recognize Dr. Crockett as an expert on elective medical and
    surgical abortion was, in fact, because she does not perform elective abortions. While the district court will
    by the State on the narrow issue which became the central focus.
    8
    The State has not appealed the district court’s order refusing to recognize Dr. Crockett as an expert in the critical review
    of medical literature. Although that order has not been placed before us, the only reason the district court gave for her ruling was
    that Dr. Crockett did not have any specific training in the critical review of medical literature beyond the training incorporated
    in her general medical school and residency training. This ruling ignored Dr. Crockett’s testimony that her residency program
    at Georgetown University put particular emphasis on training residents in the critical review of medical literature, that she had
    taught classes on the subject, that she had done extensive reading and self-education on the subject, and that she had critically
    reviewed medical literature for the FDA. If these qualifications are not sufficient to demonstrate expertise, this court is hard-
    pressed to imagine what qualifications would suffice.
    No. 04-4371             Planned Parenthood, et al. v. Taft, et al.                                      Page 10
    have to resolve this issue at the trial on the merits, this court need not resolve this issue now because Dr.
    Crockett’s proffered testimony, even if admitted into evidence, would not have been sufficient to defeat
    Plaintiffs’ motion for a preliminary injunction.
    Dr. Crockett’s proffered testimony addressed two topics. First, she criticized the studies relied upon
    by Plaintiffs’ experts to show the efficacy of the Schaff protocol as compared to the FDA-approved
    protocol. Dr. Crockett opined that Dr. Schaff’s studies manipulated the numbers to make his protocol
    appear more effective than the FDA protocol. However, whether the Schaff protocol is effective ninety-five
    percent of the time (as asserted by Plaintiffs) or ninety percent of the time (as asserted by the State) does
    not determine whether the Act must contain a health or life exception. Second, Dr. Crockett opined that the
    lower dosage of mifepristone used in the Schaff protocol might only be effective because of the larger
    dosage of misoprostol used. This point is also not related to the central issue. Since Dr. Crockett’s
    proffered testimony does not affect the issue on appeal, there is no reason to scrutinize the district court’s
    evidentiary ruling.
    VI.
    The State’s final argument is that the district court erred by enjoining the entire Act, including the
    reporting and record-keeping provision which Plaintiffs do not argue is unconstitutional. The State has not
    argued that even if the Act was required to contain a health or life exception, the preliminary injunction
    should have only enjoined those particular applications of the Act which would have posed a significant risk
    to a woman’s health or life. At the time this case was briefed and argued, there was not any concrete
    support for such an argument. However, after oral argument was heard in this case, the Supreme Court held
    that when an abortion statute lacks a constitutionally necessary health or life exception, a narrow injunction
    prohibiting only unconstitutional applications of the statute should be employed where such an approach
    is not contrary to legislative intent. Ayotte v. Planned Parenthood of Northern New England, — U.S. —,
    
    126 S. Ct. 961
    (2006).
    Plaintiffs claim that the State’s severability argument with respect to the reporting and record-
    keeping provision of the Act is not properly raised on appeal because it was not adequately presented to the
    trial court. In spite of the State’s protestations to the contrary, Plaintiffs are correct that the State waived
    its severability argument at the preliminary injunction stage. However, this issue is intertwined with the
    broader issue of whether the scope of the preliminary injunction was appropriate in light of the Ayotte
    decision. Although the State did not pose this broader challenge, it can hardly be faulted for failing to raise
    an argument before there was legitimate legal support for such an argument. Regarding an argument as
    waived under such circumstances would be both inequitable and counterproductive. Hormel v. Helvering,
    
    312 U.S. 552
    , 557-59 (1941) (noting an efficiency rationale for addressing waived issues where intervening
    case authority might change the result). Parties would be forced to either litter their pleadings with every
    argument which might conceivably be adopted during the pendency of a proceeding or forgo the benefit of
    any new relevant case law.
    In Ayotte, the Supreme Court held that “[i]f enforcing a statute that regulates access to abortion
    would be unconstitutional in medical emergencies,” then “invalidating the statute entirely is not always
    necessary or 
    justified.” 126 S. Ct. at 964
    . Instead, “lower courts may be able to render narrower declaratory
    and injunctive relief,” namely the prohibition of the statute’s unconstitutional applications. 
    Id. at 964,
    969.
    Invalidating the statute in toto is still appropriate, however, if the legislature would “prefer[] no statute at
    all to a statute enjoined in [this] way.” 
    Id. at 969.
    The Court vacated the First Circuit’s opinion affirming
    the district court’s order granting a permanent injunction and remanded the case for the lower courts in the
    first instance to determine the legislative intent. 
    Id. at 966,
    969. Notably, the Court did not vacate the
    underlying injunction itself. This silence as to the injunction is significant because the Court has not
    hesitated to vacate all or part of an injunction explicitly when it so desires. E.g., Scheidler v. Nat’l Org. for
    Women, Inc., 
    537 U.S. 393
    , 411 (2003); Morales v. Trans World Airlines, Inc., 
    504 U.S. 374
    , 382-83
    (1992); see also Branch v. Smith, 
    538 U.S. 254
    , 265 (2003).
    No. 04-4371              Planned Parenthood, et al. v. Taft, et al.                                         Page 11
    Given the absence of a new automatic-vacatur rule in Ayotte, it is appropriate simply to adhere to
    the usual approach to overbroad injunctions. Cf. United States v. Booker, 
    543 U.S. 220
    , 
    125 S. Ct. 738
    , 769
    (2005) (instructing the courts of appeals to use “ordinary prudential doctrines” when applying Booker to
    cases pending on direct appeal). The courts’ practice has long been to vacate an injunction only insofar as
    it is too broad, leaving the balance intact. E.g., 
    Morales, 504 U.S. at 382-83
    (vacating in part an injunction
    prohibiting state officers from enforcing state law — under the doctrine of Ex Parte Young, 
    209 U.S. 123
    (1908) — “insofar as it restrain[ed] the operation of state laws” that the officers had not threatened to
    enforce); Tumblebus Inc. v. Cranmer, 
    399 F.3d 754
    , 768 (6th Cir.) (vacating and remanding for further
    factfinding one part of a preliminary injunction while affirming the other part), cert. denied, — U.S. —, 
    126 S. Ct. 361
    (2005); PACCAR Inc. v. TeleScan Techs., L.L.C., 
    319 F.3d 243
    , 258 (6th Cir. 2003) (affirming
    in part and vacating in part a preliminary injunction where “the scope of the injunction [was] too broad”);
    Michigan State AFL-CIO v. Miller, 
    103 F.3d 1240
    , 1244, 1253 (6th Cir. 1997) (vacating a preliminary
    injunction prohibiting enforcement of three statutory sections only “insofar as it applie[d] to” one section);
    Sheeran v. American Commercial Lines, Inc., 
    683 F.2d 970
    , 981 (6th Cir. 1982) (generally affirming a
    preliminary injunction but modifying it as to one defendant and vacating it as to another); Blaylock v.
    Cheker Oil Co., 
    547 F.2d 962
    , 966 (6th Cir. 1976) (vacating one provision of a preliminary injunction while
    affirming three others); see also 
    Branch, 538 U.S. at 265
    (affirming one basis of an injunction but vacating
    an alternative ground). Although it went unmentioned in Ayotte, the Supreme Court has even employed this
    approach in the context of an injunction prohibiting the enforcement of an abortion regulation. Guste v.
    Jackson, 
    429 U.S. 399
    , 400 (1977) (per curiam) (noting that the injunction “appear[ed] to extend to the
    entire statute” and vacating the injunction “insofar as it bars enforcement of the ‘informed consent’
    requirements”).
    In light of this well-established method of dealing with overbroad injunctions, the proper course is
    to vacate in part the district court’s order, leaving the preliminary injunction undisturbed insofar as it
    prohibits unconstitutional applications of the statute. On remand, the district court must determine whether
    a broader injunction is still required by considering the legislative         intent and the Plaintiffs’ as-yet-
    unaddressed vagueness, bodily integrity, and undue burden claims.9 
    Ayotte, 126 S. Ct. at 969
    (explaining
    that if the legislature “preferred no statute at all to a statute enjoined” in its unconstitutional applications,
    then “consistency with legislative intent requires invalidating the statute in toto”); Planned Parenthood
    Fed’n of America, Inc. v. Gonzales, — F.3d —, 
    2006 WL 229900
    , at *17-20 (9th Cir. 2006) (noting that
    the court might have been able to draft a narrowly drawn injunction consistent with the legislative intent
    if the statute’s only constitutional infirmity was the lack of a health exception but ultimately invalidating
    the entire statute because it was also unconstitutionally vague and imposed an undue burden).
    VII.
    The only aspect of the district court’s preliminary injunction analysis which the State challenges is
    its conclusion that Plaintiffs established a strong likelihood of prevailing on the merits. The State has not
    questioned the district court’s conclusion that the remaining preliminary injunction factors of irreparable
    injury, the interests of third parties, and the public interest also weighed in favor of granting the preliminary
    injunction. The district court’s primary basis for concluding that Plaintiffs had established a strong
    likelihood of success on the merits was the conclusion that every statute which regulates abortion must
    contain a health or life exception. This holding was error. However, the district court alternatively held that
    Plaintiffs were likely to succeed on the merits even if the health or life exception requirement was not a per
    se requirement because substantial medical evidence had been presented that the Act could pose a
    significant risk to women’s health or lives. Based on the evidence presented at the preliminary injunction
    stage, this conclusion was not an abuse of discretion. Consequently, there is no basis for overturning the
    district court’s determination that Plaintiffs had established a strong likelihood of succeeding on the merits
    9
    Nothing in our decision today prohibits consideration on remand of the changed stance of the American College of
    Obstetricians and Gynecologists, which now supports the mifepristone protocol at issue in this case.
    No. 04-4371             Planned Parenthood, et al. v. Taft, et al.                                    Page 12
    of their claim that the Act is unconstitutional because it lacks a health or life exception. However, in light
    of Ayotte, the validity of the broad preliminary injunction entered by the district court must be reconsidered.
    For the reasons discussed above, this court need not address the merits of the State’s remaining claims of
    error. The district court’s order is AFFIRMED in part and VACATED in part. We AFFIRM the
    preliminary injunction insofar as it prohibits unconstitutional applications of the Act, but VACATE the
    preliminary injunction insofar as it prohibits constitutional applications of the Act. The case is
    REMANDED for the district court to determine the appropriate scope of preliminary injunctive relief
    consistent with this opinion.
    No. 04-4371             Planned Parenthood, et al. v. Taft, et al.                                       Page 13
    _________________
    CONCURRENCE
    _________________
    KAREN NELSON MOORE, Circuit Judge, concurring in part. Because I agree that Plaintiffs have
    satisfied the preliminary-injunction standard of demonstrating a strong likelihood of prevailing on the
    merits, I join Parts I though IV of the majority opinion. I also agree that in light of Ayotte v. Planned
    Parenthood of Northern New England, — U.S. —, 
    126 S. Ct. 961
    (2006), the preliminary injunction should
    be vacated in part and the case remanded to the district court to reconsider the scope of the injunction. Thus,
    I join Parts VI and VII. Finally, I join Part V only insofar as it recognizes that the district court’s limitation
    of the state’s expert-witness testimony is irrelevant to the outcome of this appeal. This irrelevance is
    precisely why I cannot, however, endorse the majority’s needless dicta on the merits of the evidentiary
    question.
    Plaintiffs presented significant evidence on the safety benefits of the banned abortion procedure.
    The state attempted to counter this evidence with the testimony of its expert witness, Dr. Susan Crockett,
    but the district court excluded some of her testimony. The state now appeals this evidentiary ruling. The
    Supreme Court has instructed us that in these circumstances, Dr. Crockett’s testimony is irrelevant: “Where
    a significant body of medical opinion believes a procedure may bring with it greater safety for some patients
    and explains the medical reasons supporting that view, we cannot say that the presence of a different view
    by itself proves the contrary.” Stenberg v. Carhart, 
    530 U.S. 914
    , 937 (2000). Because Plaintiffs presented
    “a significant body of medical opinion” supporting their position, Dr. Crockett’s “different view” could not
    have affected the merits. Id.; Richmond Med. Ctr. for Women v. Hicks, 
    409 F.3d 619
    , 625 n.1 (4th Cir.
    2005) (“Even if we assumed without deciding that the district court abused its discretion in excluding the
    Commonwealth’s opinion evidence, the consideration of that evidence would not change our result.”),
    petition for cert. filed, 
    74 U.S.L.W. 3352
    (U.S. Dec. 1, 2005) (No. 05-730). Thus, it matters not a whit that
    the testimony was excluded. See FED. R. EVID. 103(a) (“Error may not be predicated upon a ruling which
    admits or excludes evidence unless a substantial right of the party is affected . . . .”).
    Presumably in recognition of Stenberg, the majority states that “this court need not resolve this issue
    now because Dr. Crockett’s proffered testimony, even if admitted into evidence, would not have been
    sufficient to defeat Plaintiffs’ motion for a preliminary injunction.” Majority Op. at 10. It reiterates that
    “there is no reason to scrutinize the district court’s evidentiary ruling.” 
    Id. Unfortunately, the
    majority
    ignores its own advice, as it proceeds to “scrutinize” the evidentiary ruling even though “there is no reason”
    to do so. Because the evidentiary issue has no impact on the outcome of this appeal, I do not join the
    majority’s dicta regarding this evidence.
    

Document Info

Docket Number: 04-4371

Filed Date: 2/24/2006

Precedential Status: Precedential

Modified Date: 9/22/2015

Authorities (26)

Planned Parenthood of Northern New England v. Heed , 390 F.3d 53 ( 2004 )

richmond-medical-center-for-women-william-g-fitzhugh-md-on-behalf-of , 409 F.3d 619 ( 2005 )

Lexmark International, Inc. v. Static Control Components, ... , 387 F.3d 522 ( 2004 )

Tumblebus Inc. v. Meredith Cranmer, D/B/A Tumblebus of ... , 399 F.3d 754 ( 2005 )

Gary Blaylock v. Cheker Oil Company, an Illinois Corporation , 547 F.2d 962 ( 1976 )

Nightclubs, Inc.,plaintiff-Appellant v. City of Paducah , 202 F.3d 884 ( 2000 )

United States v. Edward Rose & Sons, Dorchen/martin ... , 384 F.3d 258 ( 2004 )

American Civil Liberties Union of Ohio, Inc. v. Robert Taft,... , 385 F.3d 641 ( 2004 )

Paccar Inc. v. Telescan Technologies, L.L.C. , 319 F.3d 243 ( 2003 )

The Taubman Company v. Webfeats, a Texas Company and Henry ... , 319 F.3d 770 ( 2003 )

Secretary of Labor, United States Department of Labor v. ... , 317 F.3d 534 ( 2003 )

thomas-m-sheeran-acting-director-of-region-9-of-the-national-labor , 683 F.2d 970 ( 1982 )

Doris Berry, Personal Representative of the Estate of Lee F.... , 25 F.3d 1342 ( 1994 )

michigan-state-afl-cio-a-voluntary-unincorporated-labor-association , 103 F.3d 1240 ( 1997 )

Ex Parte Young , 28 S. Ct. 441 ( 1908 )

Hormel v. Helvering , 61 S. Ct. 719 ( 1941 )

leroy-carhart-md-on-behalf-of-themselves-and-the-patients-they-serve , 413 F.3d 791 ( 2005 )

reproductive-health-services-of-planned-parenthood-of-the-st-louis-region , 429 F.3d 803 ( 2005 )

planned-parenthood-of-idaho-inc-glenn-h-weyhrich-md-v-lawrence , 376 F.3d 908 ( 2004 )

Ayotte v. Planned Parenthood of Northern New Eng. , 126 S. Ct. 961 ( 2006 )

View All Authorities »